Table 3 Functional pathway analysis of metabolites associated with MDD with full remission.
Pathway name | Match status | Metabolitesa | P | FDR | Impact |
---|---|---|---|---|---|
Alanine, aspartate and glutamate metabolism | 3/24 | Pyruvic acid, glutamine, succinic acid | <ā0.001 | 0.002 | 0.207 |
Aminoacyl-tRNA biosynthesis | 4/75 | Histidine, glutamine, glycine, proline | <ā0.001 | 0.002 | 0.000 |
Arginine and proline metabolism | 4/77 | Glutamine, proline, creatine, pyruvic acid | <ā0.001 | 0.002 | 0.134 |
Nitrogen metabolism | 3/39 | Glutamine, histidine, glycine | <ā0.001 | 0.004 | 0.000 |
Glycine, serine and threonine metabolism | 3/48 | Glycine, creatine, pyruvic acid | <ā0.001 | 0.006 | 0.188 |
Taurine and hypotaurine metabolism | 2/20 | Pyruvic acid, acetic acid | 0.002 | 0.020 | 0.022 |
Citrate cycle (TCA cycle) | 2/20 | Succinic acid, pyruvic acid | 0.002 | 0.020 | 0.105 |
Glycolysis or Gluconeogenesis | 2/31 | Pyruvic acid, acetic acid | 0.004 | 0.041 | 0.096 |
Pyruvate metabolism | 2/32 | Pyruvic acid, acetic acid | 0.005 | 0.041 | 0.282 |